LANCANG TEA(06911): Wang Juan is appointed as a non-executive director
Lancang Ancient Tea (06911) announced that Ms. Wang Juan has resigned from the board of directors on January 5, 2025 due to personal health reasons.
LANCANG TEA (06911) announced that Ms. Wang Juan has submitted a written resignation to the board of directors on January 5, 2025 due to personal health reasons. As a result, she has decided to resign from her positions as a member of the board of directors' Remuneration and Assessment Committee, a member of the board of directors' Strategic Committee, and the company's general manager, effective from January 5, 2025.
In light of Ms. Wang Juan's resignation from the position of general manager, the board of directors resolved on January 6, 2025 to appoint her as a non-executive director; and to elect Ms. Du Chunyi, the chairman and executive director of the company, as the interim acting general manager, effective from the date of the board's approval until the appointment of a new general manager.
The board of directors resolved on January 6, 2025 to elect Mr. Liu Jiajie, an executive director, as a member of the board of directors' Strategic Committee; and Dr. Yang Kequan, an independent non-executive director, as a member of the board of directors' Remuneration and Assessment Committee, effective from January 6, 2025.
Dr. Xie Xiaoyao has submitted a written resignation to the board of directors on January 4, 2025 due to other work arrangements. As a result, he has decided to resign from his positions as an independent non-executive director of the company, chairman of the board of directors' Remuneration and Assessment Committee, chairman of the board of directors' Nomination Committee, and a member of the board of directors' Audit Committee.
Related Articles

GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.
GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.

RECOMMEND

Trump Signals End to Trade Talks, Vows to Impose Tariffs Unilaterally Ahead of July 9 Deadline
30/06/2025

One License Unlocks HKD 23.4 Billion Surge: Unpacking Hong Kong’s Ambitions as a Global Virtual Asset Hub
30/06/2025

16 Companies Submit IPO Applications in One Day; Hong Kong IPO Fundraising Hits Three-Year High
30/06/2025